LincRNA-RoR/miR-145 promote invasion and metastasis in triple-negative breast cancer via targeting MUC1.

导出 LinkOut

翻译打印收藏纠错

作者： Jianli,Ma ^[1] ; Yue,Yang ^[2] ; Desheng,Huo ^[3] ; Zanyu,Wang ^[4] ; Xiaoyu,Zhai ^[5] ; Jing,Chen ^[6] ; Huixin,Sun ^[2] ; Weiwei,An ^[2] ; Jing,Jie ^[7] ; Pengxiang,Yang ^[8]

作者单位： Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, 150081, China. ^[1] Institute of Cancer Prevention and Treatment, Heilongjiang Academy of Medical Science, Harbin Medical University, Harbin, 150081, China. ^[2] Department of Histology and Embryology, College of Basic Medical Science, Jilin University, Changchun 130021, China. ^[3] Heilongjiang Veterinary Drug and Feed Supervision Institute, Harbin, 150040, China. ^[4] Department of Immunology, College of Basic Medical Science, Jilin University, Changchun, 130021, China. ^[5] Department of Pancreatic Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China. ^[6] Department of Immunology, College of Basic Medical Science, Jilin University, Changchun, 130021, China. Electronic address: jiejing1103@126.com. ^[7] Institute of Cancer Prevention and Treatment, Heilongjiang Academy of Medical Science, Harbin Medical University, Harbin, 150081, China; Tianjin Key Laboratory of Biomaterial Research, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, 300192, China. Electronic address: yangpengxiang@163.com. ^[8]

关键词 Invasion and metastasis LincRNA-ROR MUC1 Triple-negative breast cancer